An audit of management of differentiated thyroid cancer in specialist and non-specialist clinic settings

被引:22
作者
Kumar, H
Daykin, J
Holder, R
Watkinson, JC
Sheppard, MC
Franklyn, JA [1 ]
机构
[1] Univ Birmingham, Queen Elizabeth Hosp, Dept Med, Div Med Sci, Birmingham B15 TH, W Midlands, England
[2] Univ Birmingham, Queen Elizabeth Hosp, Div Math & Stat, Birmingham B15 TH, W Midlands, England
关键词
D O I
10.1046/j.1365-2265.2001.01288.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Thyroid cancer is the most common endocrine malignancy but is none the less rare. Some aspects of its management remain controversial. Previous audits of patient management in the United Kingdom have revealed deficiencies, especially in communication between specialists. We have audited patient management in a large university-associated teaching hospital, assessing points of good practice identified from published guidelines and reviews, and have compared findings in groups of patients managed jointly by specialists with an interest in thyroid cancer (including surgeon, endocrinologist and oncologist) with a group managed by other clinicians outside that setting. DESIGN AND PATIENTS Retrospective case-note review of 205 patients with differentiated (papillary or follicular) cancer including group A (n = 134; managed in a specialist multi-disciplinary clinic setting) and group B (n = 71; managed in other clinic settings). Points of good practice investigated were adequacy of surgery, surgical complications, prescription and adequacy of 14 treatment, adequacy of monitoring by measurement of serum thyroglobulin and action taken and appropriate administration of ablative radioiodine. RESULTS Deficiencies in management of the cohort as a whole were identified, including inadequate surgery and inadequate TSH suppression in approximately one-fifth of the cases. Monitoring with thyroglobulin measurements and action when serum thyroglobulin was high were also inadequate in some cases and ablative radioiodine was not given, despite being indicated in 11.7% of the cohort. Inadequate surgery and failure to administer radioiodine were less common in those managed in a specialist clinic setting than in those managed in other clinic settings. CONCLUSIONS The findings highlight the need for locally agreed protocols in managing relatively rare endocrine disorders such as thyroid cancer and argue in favour of centralization of expertise and patient management in multi-disciplinary specialist clinic settings.
引用
收藏
页码:719 / 723
页数:5
相关论文
共 28 条
[1]   Age and gender predict the outcome of treatment for Graves' hyperthyroidism [J].
Allahabadia, A ;
Daykin, J ;
Holder, RL ;
Sheppard, MC ;
Gough, SCL ;
Franklyn, JA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03) :1038-1042
[2]  
*AM ASS CLIN END, 1996, ENDOCRINE PRACTICE, V2, P78
[3]  
*AM ASS CLIN END, 1997, ENDOCR PRACT, V3, P60
[4]   THE COMPARATIVE VALUE OF SERUM THYROGLOBULIN MEASUREMENTS AND I-131 TOTAL-BODY SCANS IN THE FOLLOW-UP-STUDY OF PATIENTS WITH TREATED DIFFERENTIATED THYROID-CANCER [J].
ASHCRAFT, MW ;
VANHERLE, AJ .
AMERICAN JOURNAL OF MEDICINE, 1981, 71 (05) :806-814
[5]   SHOULD ONE MEASURE SERUM THYROGLOBULIN IN THE PRESENCE OF ANTI-THYROGLOBULIN ANTIBODIES [J].
BLACK, EG ;
HOFFENBERG, R .
CLINICAL ENDOCRINOLOGY, 1983, 19 (05) :597-601
[6]   SERUM THYROGLOBULIN MEASUREMENTS IN THYROID-CANCER - EVALUATION OF FALSE POSITIVE RESULTS [J].
BLACK, EG ;
SHEPPARD, MC .
CLINICAL ENDOCRINOLOGY, 1991, 35 (06) :519-520
[7]  
BLACK EG, 1981, LANCET, V2, P443
[8]   Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: Results from the National Thyroid Cancer Treatment Cooperative Registry [J].
Cooper, DS ;
Specker, B ;
Ho, M ;
Sperling, M ;
Ladenson, PW ;
Ross, DS ;
Ain, KB ;
Bigos, ST ;
Brierley, JD ;
Haugen, BR ;
Klein, I ;
Robbins, J ;
Sherman, SI ;
Taylor, T ;
Maxon, HR .
THYROID, 1998, 8 (09) :737-744
[9]  
CORREA P, 1995, CANCER, V75, P338, DOI 10.1002/1097-0142(19950101)75:1+<338::AID-CNCR2820751316>3.0.CO
[10]  
2-F